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HAEMODIALYSIS
The effective treatment for renal failure dates from the invention during World
War 11 of the first workable artificial kidney by Dr Wilhelm Kolff in Klampen in
occupied Holland. He demonstrated that it is possible to remove waste products
of metabolism from the bloodstream, thereby cleansing the body when the
kidneys have failed. Moreover, he showed that clinical improvement followed
rapidly. By repeated use ofthis treatment, some patients could be kept alive long
enough for their own kidneys to regain normal function. As far as I am aware, he
provided the first evidence that acute renal failure need not be irreversible. While
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Fig 1. One of Kolff's rotating drum artificial
kidneys, first developed about 1948.
the idea of removing toxic substances
from the bloodstream was not new,
Kolff was the first to devise practical
equipment for this purpose (Fig 1).
The patient's blood was passed from a
cannula in the radial artery into a long
tube of cellophane sausage-skin which
was wound around a supporting drum-
shaped framework. The frame rotated
on a spindle so that the blood-filled
tubing was bathed in a tank containing
dialysis fluid. The cleansed blood was
returned by another cannula inserted
into a convenient larae vein and the
process repeated until the biochemical abnormalities were considerably amelior-
ated. The blood was prevented from clotting by repeated injection of heparin into
the blood circuit.
Kolff went on to devise an improved artificial kidney in which the cellophane
tubing is contained within a compact coil, the necessary large surface area
provided by two tubes, the bloodstream being divided into two to supply each
tube. This design was capable of being manufactured and sterilized ready for use
- the first disposable kidney. In all coil dialysers the dialysis fluid is pumped
around the blood-filled dialysis membrane, rather than the tubing itself being
rotated through a stationary bath of dialysis fluid. The coil is supported in a
container and the dialysis fluid is pumped through the coil and splashes back into
the bath to be recirculated again. Fig 2 shows the twin-coil kidney with which we
began our service for renal failure in Belfast in 1959.
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Several other forms of artificial kidney
have been devised. These include flat
plate dialysers in which two sheets of
dialysis membrane are sandwiched
between plates of polypropylene which
are engravedwith grooves, along which
the dialysis fluid is pumped and passed
to waste. The prototype of this was
designed by Kiil in 1960 and uses two
such sandwiches. The artificial kidney
now most widely used is the capillary
kidney in which the blood is passed
through enormousnumbersofcapillary
tubes made of dialysis membrane,
around which the dialysis fluid is
pumped.
After the War, Kolff gave artificial
kidneys to Hammersmith Hospital in
London, Mount Sinai Hospital in New
York, and the Royal Victoria Hospital
in Montreal, all of whom reported
successful treatments. Sadlythekidney
which hegave toAmsterdam wasnever
used. The artificial kidney stimulated
interest in the kidney, its functions and its diseases. At Hammersmith Hospital
there was very active interest in the kidney when Dr Graham Bull came as a
Research Fellow from Cape Town in 1948. He was involved, with Milne, Borst
and others, in the early use of the artificial kidney. By his accounts the original
Kolff with its wooden tank and framework was difficult to set up and patients
developed convulsions and rigors during treatment. He became more interested
in water and electrolyte balance and the dietary management of renal failure,
and published seminal papers with Borst and Milne.1 2 They developed the
subsequently famous Bull-Borst diet, a protein-free regimen which provided
energy as pure carbohydrate and oil. The aim was to provide enough energy to
prevent wasting of body tissues, thus sparing nitrogen production, without giving
sodium and potassium. The diet was difficult to take, the patients became
nauseated by the mixture of glucose or lactose and oil, and developed sore
mouths. Equally important was the concept of fluid restriction, because patients
with uraemia become thirsty, and, ifallowed to drink freely, develop oedema and
then heart failure. Graham Bull was appointed the first full-time Professor of
Medicine in Queen's University in 1952, bringing to Belfast the new expertise in
management ofkidney diseases. I had the good fortune tojoin his Department as
an MRC Research Fellow in 1953.
DEVELOPMENT OF HAEMODIALYSIS IN BELFAST
Up to this time Professor Bull had maintained that most patients with acute renal
failure would recover with conservative treatment and that the population of
Northern Ireland was not big enough to justify an artificial kidney. In 1958, the
son of one of our consultant obstetricians developed acute renal failure following
a road traffic accident. Conservative treatment did not seem to be enough and he
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was flown to Hammersmith, where it was found he was already producing urine
again and he did not need dialysis after all. However, questions were asked in
Stormont about the need for an artificial kidney for Northern Ireland, with the
result that it was decided to set uD a Renal Unit in the Belfast City HosDital. The
Fig 3. John Mcllroy Megaw, FRCSEd,
consultant surgeon at the Belfast City
Hospital, 1948.71.
choice of the City Hospital for the siting of
the new service was due to the late Mr John
Megaw (Fig 3). I was given the task of
setting up the service, with the grade of
Junior Hospital Medical Officer, in 1958, to
be elevated to Senior Hospital Medical
Officer in 1960.
The artificial kidney arrived one day in early
June 1959 but the ward was not ready for
occupation for another nine months. It
happened that a GP refresher course was
being held at the City Hospital two days
later and Mr Megaw, always an enthusiast,
insisted that I should set it up and
demonstrate it to the GPs. By this time a
technician, Mr Maurice Bingham, had been
recruited from the Biochemistry Laboratory
to assist me. I had seen a twin coil once; he
had never seen one at all. The pair of us read
the booklet, which came with the apparatus,
and proceeded to set it up using red ink to
mimic the blood circuit, much to the satis-
faction of Mr Megaw and his class of GPs.
Meantime, Dr Eliahou from Israel, who was
finishing a year's attachment with Professor
Bull. Iearned of the arrival of our eauinment
and wanted to see it in action before departing for home. Professor Welbourn tied
the ureters of a dog and we waited 48 hours for it to become uraemic. Our first
haemodialysis was carried out in the animal theatre in the Department ofSurgery.
Wemanaged togive thedog ashort dialysis, enough to demonstrateasatisfactory
fall in blood urea. Dr Eliahou returned to Israel where he later set up the Renal
Unit in Tel Aviv, and he is now a world expert on acute renal failure.
At this point, I felt that I was ready to visit the Renal Unit at Halton to see how
dialysis should really be carried out. However, the following week an elderly man
was admitted in uraemia due to prostatism. He was semicomatose with a blood
urea over 600 mg/100 ml. Mr Megaw demanded that I should treat him by
dialysis. 'You dialysed a dog last week, you cannot let my patient die without
trying'. Mr Maurice Bingham and I set up the twin coil kidney in Ava 2 theatre
(which no longer exists) and Miss Eileen Martin, the Medicine Department
technician, weighed out three sets of chemicals to make up three changes of the
dialysis fluid. Mr Megaw inserted the cannulae in the radial artery and cephalic
vein, and in fear and trepidation we treated our first patient. My stepson, John
Freeland, sat in my car atthe front ofthe Ava to act as messenger. WhenI wanted
to send a blood sample to the laboratory, orwhen I needed to have an extra set of
chemicals weighed out after I had stupidly spoilt one bath of dialysis fluid, I just
stuck my head out of the window and hollered for him to come up. It was a very
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successful treatment in that the blood urea fell from around 600 mg/100 ml to
200 mg/100 ml after about six hours, and the patient wakened up. Unfortunately
he died within a week from a cerebrovascular accident.
From then on we were in business. We were still without the promised accommo-
dation in Ward 9, and our headquarters consisted of a small room in Ward 15
formerly used as a store. The hospital van took us and the kidney to the patient,
most often to the Royal Victoria Hospital where we dialysed many times in the
classroom between Wards 1 and 2, and 3 and 4, in the old ward theatres and
later in Ward 22 where Dr Gray was beginning to provide ventilation for patients
with respiratory failure. The second patient recovered from 36 days of virtual
anuria and was well when I last heard of her a few years ago, more than 20 years
later. Another early recovery from acute renal failure after an incompatible blood
transfusion is working in the Wakehurst Unit. Not all the patients recovered but,
looking back at those early days, the recovery rate seems to have been higher
than it is now. This is probably because patients with grave injuries or illness are
now resuscitated and live long enough to develop renal failure but may not
survive other complications, sometimes dying after renal function has returned.
And so I never got to Halton to see how dialysis should be done, and was entirely
taught by the book.
There were many problems for our travelling dialysis service. Plugs never fitted
and there always seemed to be a problem about the water supply. The team
consisted of Maurice, replaced in the spring of 1960 by Mr Jack Lyness, and
myself. About two hours were needed to prepare the apparatus; the treatment
lasted six hours, with another hour or more to clear up. It never seemed possible
to complete the procedure in less than 10 hours.
Things became easier when we moved into the new unit in Ward 9. Thereafter
the patients were brought to us, except for the very seriously ill on respirators.
I was still the only doctor; there was no question of a rota. Eventually, in 1963, 1
was able to persuade Matron that we needed our own nurse and Staff Nurse Kay
Maguire was appointed. She has contributed enormously to the development of
the service and as Senior Nursing Officer leads the now large nursing team. From
this point the work increased greatly and patients with undiagnosed renal failure
began to be admitted. Many of these had chronic renal failure. At that time the
artificial kidney was not used for treatment of chronic renal failure because all
available superficial blood vessels were soon used up. This situation was changed
in 1960 by the invention by Scribner3 of an external shunt between artery and
vein, which could be opened for treatment, then reunited as a shunt. This could
be repeated many times allowing treatment to be continued almost indefinitely.
Our first arteriovenous shunt was inserted by Mr Will Hanna, then a senior
registrar, in 1964. The first patient died from septicaemia after a short time. This
occurred because we attempted to make the treatment less expensive, re-using
the twin coil by washing it free from blood with saline and storing it in the
refrigerator between treatments. His brother was to become our first transplant
later on. Both brothers had renal failure from polycystic disease.
The second patient commenced treatment in January 1965, and soon became
well enough to live at home, returning twice a week for treatment; thus we were
able to keep her well but were prevented from accepting any new patient. She
had a transplant in St Mary's Hospital, London, in 1965, which functioned well
for seven years, eventually being lost due to a deep venous thrombosis which
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followed an aeroplanejourney. This transplant led to a partnership with Professor
Peart's unit and a regular small trickle of patients was sent to London for the
transplant operation, returning to Belfast for long-term supervision of the
immunosuppressive treatment necessary to prevent rejection of the graft. I will
return to the transplant story later.
By this time the flat plate kidney had appeared. This had several advantages for
treatment of patients requiring regular haemodialysis, the most important of
which was that the volume of the complete blood circuit was much less than that
of the twin coil kidney. This meant that the kidney could be primed with saline
instead of blood which was needed for the larger volume coils. Moreover the cost
of the cupraphane membrane sheets was very little compared with coils costing
£22.00 in 1965 money. An engineer in London called Heppel made a copy of
the original Swedish model for treatment ofhis wife in the Royal Free Hospital. He
later set up a small business to manufacture Kiil kidneys. He was kind enough to
let me have two sets on the understanding that I would pay for them some time.
We set to and taught ourselves how to build the brutes, by sweat and tears.
Professor Love may remember finding me one Saturday literally in tears because
the wretched kidney developed a leak every time it was tested. There were many
new tricks to that trade which had to be learnt.
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The Kiil kidney is flushed by fresh
dialysis fluid at the rate of half-a-litre
per minute, and, as the treatments
then lasted 14 hours, a large volume of
dialysis fluid was required (Fig 4). The
necessary salts had to be weighed out
and the fluid mix prepared in a huge
plastic fish tank, containing 400 litres.
We ordered our tank but it was not to
be ready for several months so we set
about treating two patients in a make-
shift way using the 100-litre tank ofthe
original coil kidney. The patients were
treated at night so that the coil kidney
could be used during the day for the
acute service. Mr Megaw kindly lent us
one of his two cystoscopy theatres for
this purpose. The tank of fluid had to
be replenished four times during the
night. The service was possible only
because MrJackLyness volunteeredto
sleep on a couch in the surgeons' room
four nights a week, to be awakened by
the night nurse when the fluid level
went down toa critical point. Mr Lyness
did this in addition to his davtime duties
for about six months until the new tanks arrived. The cleansing of the Kiil kidneys
presented a problem. It is horrifying now to think that, oblivious to the perils of
hepatitis B, the bloodstained Kiils were carried the length of Ward 9 to the
bathroom at the far end where they were scrubbed in the patients' bath. The
dialysis tanks had to be scrubbed and sterilised with hypochlorite and, on
occasions, our washings leaked through to Casualty situated just beneath us. At
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one stage, patients frequently developed rigors during dialysis, but the cause
eluded us for some time. Eventually we discovered pigeon droppings in the water
tank which supplied the Unit. The rigors disappeared when we installed a direct
supply from the water main.
In 1964 it was envisaged that there would be a haemodialysis unit in the new
Tower Block, and in that year I drew a sketch plan, with the enthusiastic help of
Mr Paddy Semple, of what I thought was required. In 1965 it became clear that
some provision for the growing needs of the Renal Unit would be necessary long
before the most optimistic estimate for the opening of the Tower Block. The only
way this could be provided was by a new building behind Ava, as there was no
space available in the main hospital. The successful treatment of our second
patient by regular haemodialysis, followed by transplantation, determined us to
develop a service for the treatment of chronic renal failure, which would include
transplantation. There was still no other doctor assigned to the Unit though some
of Professor Bull's British Council Research Fellows worked with us from time to
time to gain practical experience in the management of renal failure. From 1960
onwards a succession of British Council Fellows came to Belfast for the specific
purpose of working in the Renal Unit, a number of whom stayed long enough
to acquire a PhD. They were Doctors P Metaxis, A Billis, N Papadoyannakis,
D G Oreopoulos (all from Greece), R Gupta, J Jindal (India), H Goetz (Hamburg),
I Taraba (Hungary), and M A 0 Soyannwo (Nigeria).
The first phase of the building, now known as Renal 1, was ready in July 1968. It
contains six single-patient rooms, a theatre and a two-bed dialysis room, later to
become the transplant theatre, plus the usual offices. The patient rooms are
situated between 'clean' and 'dirty' corridors, communicating with each. The staff
enter the Unit through changing rooms, as to a theatre suite. All medical and
nursing care is provided from the 'clean' corridor. Disposal of used items is via
pass-through cupboards to the 'dirty' corridor. Each area has its own air supply
and differential pressure ventilation ensures that air flows from 'clean' towards
'dirty' areas. The system provides good quality reverse barrier nursing, without
need of airlocks, provided that the discipline of usage is carried out meticulously.
The design of the Unit makes it possible to nurse patients with low white cell
counts due to immunosuppression, who are very susceptible to infection, in
rooms adjacent to patients with acute renal failure who are often infected.
The expansion of the service has depended on a series of technical advances.
When several patients are treated simultaneously a very large volume of dialysis
fluid is required, and it is no longer feasible to make up batches of fluid in large
tanks. This problem was solved by the introduction of concentrated dialysis fluid
made commercially at 35 times the working concentration, which is diluted auto-
matically by a proportioning system of pumps controlled by conductivity meters.
The dialysis fluid is no longer recirculated, as it was in coil kidneys, but is a single
pass to waste, so that the blood is always dialysed against fresh fluid. Enormous
quantities of water are required to dilute the commercial concentrate to working
strength. The water must be purified by filtration to remove suspended 'gunk',
then passed through a de-ionizer to remove calcium and aluminium, both of
which are injurious if continuously absorbed during the many hours of treatment.
Ideally the water should have a final purification by reverse osmosis but we have
been able to dispense with this due to the good quality of Belfast water.
During the late 1970s, several systems were developed permitting dialysis by
single needle. The bloodstream is immediately divided by a Y-junction into two
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streams, one entering and one leaving the artificial kidney. The best of these
systems uses two blood pumps, the return one being set to return the blood very
rapidly to prevent mixing with the blood about to pass into the dialyser, as mixing
would obviously reduce efficiency. This extra equipment is expensive but has
obvious advantages to the patient. Thanks to the Northern Ireland Kidney
Research Fund we were able to change to single needle haemodialysis as early as
1978.
HEPATITIS
The account of haemodialysis would be incomplete without mention of hepatitis.
Hepatitis infection increased rapidly in European renal units in the late sixties. It
affected staff as well as patients and some staff members died. In 1967-68 a
transplant surgeon died in Edinburgh, and Manchester lost a doctor and a nurse.
At that time it was customary to transfuse patients on dialysis as a matter of
routine when their haemoglobin became low. It was thought that hepatitis was
spread by blood transfusion and by 1968 many units began to avoid transfusion
as much as possible. In 1969 laboratory tests for hepatitis B (formerly known as
Australia antigen) became available and a pilot study carried out by the Public
Health LaboratoryService showed that most hepatitis in renal unitswashepatitis B.
Attempts were made to control the outbreaks by testing sera from staff and
patients regularly, dialysing infected patients in isolation and improving cross-
infection precautions. Some centres trained patients with hepatitis for home
dialysis but the disease sometimes spread to family members. Hepatitis B has a
long incubation period, six weeks to six months, and these patients, unlike most
other groups of patients receiving blood transfusion, return repeatedly to hospital,
eventually becoming infective when viraemia develops. Staff and other patients
become contaminated by spillage of blood or staff pricking themselves accident-
ally with contaminated needles.
In Belfast we were fortunate to have the help of Dr John Connolly who set up the
tests very quickly, and routine testing was instituted. Renal 11 was opened in May
1972 and from the beginning followed the practices recommended by the
Rosenheim Committee. Despite this, we experienced hepatitis for the first time in
July 1972. At the beginning of June, a patient with renal failure was admitted
from a peripheral hospital, and as usual on admission had the hepatitis B antigen
test carried out which was reported as negative. He soon required regular haemo-
dialysis, and was prepared for the programme. He had his first haemodialysis in
Renal 11 on 11 July, blood being taken for a second hepatitis B test on that day as
part ofthe routine surveillance ofthe Unit. On account of the 'Twelfth' holidays, it
was not until 15 July that it was discovered that the test was positive. It then
became known that he had received transfusion the day before he came to us,
and so must have been incubating the disease. In the meantime the patient had
received a second haemodialysis in the normal way. He was then isolated in a
side-ward and a list of volunteers was drawn up to treat him. As the Unit was not
yet fully operational there had not been any sharing of equipment with any other
patient and we were optimistic that all would be well. However, three other
patients developed hepatitis, the last one in October 1972. On the advice of Dr
Sheila Polakoff from Colindale, we set up isolation dialysis in two mini-caravans
at the back of the Unit. The Unit was closed for the admission of new patients and
transplantation ceased for six months. Some patients died untreated as a result of
this action. However, no further cases developed. Three patients eventually died
but one survived, eventually to be declared non-infective and to have a transplant
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in 1973, being well with excellent graft function over 12 years later. You can
appreciate this was a very anxious time for us all, anxiety becoming acute when a
patient developed a positive test shortly after one of the nurses had pricked
herself while putting him in dialysis. Mercifully she did not develop jaundice but
later was found to have the antibody indicating sub-clinical infection.
Hepatitis now occurs only as rare sporadic cases in the UK, but it seems to be on
the increase in Europe as a whole. However, immune globulin is now available for
protection of staff and patients if there is a serious risk of infection.
PERITONEAL DIALYSIS
Over the years during which these improvements were taking place in haemo-
dialysis, other developments were occurring. It had been known from the end of
the nineteenth century that water and some other substances could pass from the
peritoneal cavity into the bloodstream and vice versa, the peritoneal membrane
acting as semipermeable membrane. From 1920 onwards numerous experi-
ments in animals and a few attempts in humans were made to usethe peritoneum
for dialysis.
Peritoneal dialysis can be carried out without special equipment other than the
plastic cannula and modified Y-piece infusion sets. In theory, at any rate, it can be
carried out in any hospital ward. Although the method is simple, great care is
needed to prevent infection ofthe peritoneal cavity. Like everything else, it works
better for the experienced. Since 1977 a new concept for the use of peritoneal
dialysis has evolved from the work of Popovich and Nolph4 in the USA. They
showed that continuous peritoneal dialysis for six or seven days per week,
changing the fluid only four times in the 24 hours, provides very effective control
of uraemia. The patients experience remarkable improvement in wellbeing. The
disadvantage of this method is a high incidence of peritoneal infection.
Oreopoulos5 in Toronto has introduced several improvements into this system.
The most important is the use of plastic containers for the dialysis fluid which,
afterthe fluid has run in, can be rolled up and carried in a pouch attached to a belt
around the waist. The same bag is then used to collect the spent dialysis fluid.
A special flexible permanent silastic cannula is used.
The CAPD method can be taught to patients of even moderate intelligence in
about two weeks, compared with the two or more months' training needed for
self-haemodialysis. The only equipment needed is a stand to support the bag
while the fluid is flowing into the peritoneum by gravity, and a small table on
which to set out a sterile towel, wipes, cleansing fluids and clamps. Storage space
is required forthe bags offluid, sterile dressing packs and the necessary cleansing
fluids. Oreopoulos has done a great deal to make CAPD an acceptable method of
treatment and continues to investigate the long-term effects. I am proud of the
fact that he received his nephrology training in Belfast and holds a PhD of
Queen's University.
RENAL TRANSPLANTATION
As long ago as 1902, Ullman in Vienna demonstrated that a kidney could be
transplanted from its normal site into the neck, and urine would be produced.
A kidney from another animal, even another species, would produce urine.
Carrell and others repeated this experiment and found that a dog whose own
kidneys had been removed would remain well for a few days, after which the
transplant ceased to function. Attempts to transplant kidneys in the human by
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Voronoy in the Ukraine in 1933 were unsuccessful, as were several attempts in
Boston in the early 1950s. About the same time, animal experiments in Boston
showed that skin could be transplanted between litter mates, the animals not
'recognising' the transplant as foreign tissue. This led tothe firstsuccessful kidney
transplant operation in 1954 by Murray, also in Boston, between identical twins.
Over the next five years, transplantation between identical twins was carried out
in a number of centres in Europe and America. Some failed for technical reasons
but in none was there evidence of rejection. An identical twin transplant carried
out in Belfast in 1962 was a technical failure.
It is obvious that few patients reaching end-stage kidney failure are fortunate
enough to have a twin able and willing to provide a kidney. The question was,
could rejection be prevented when the graft was taken from a less closely related
individual? Whole body irradiation was used to prevent rejection but the patients
died from uncontrollable sepsis because of bone marrow suppression. Attempts
were made to use immunosuppressive drugs and Roy Calne and others reported
in 1960 that mercaptopurine prolonged survival of kidney grafts in dogs but was
very toxic. Burroughs Wellcome produced a derivative of mercaptopurine,
azathioprine, which proved to be a good immunosuppressive drug and much less
toxic that the original. In 1962 azathioprine was used successfully when a kidney
taken from a patient dying during an open heart operation was transplanted into
an unrelated individual. Azathioprine thereafter became generally accepted as
the main immunosuppressive drug for transplantation for almost two decades. In
1962 Goodwin reported successful treatment of several rejection episodes with
steroid, in a mother-to-child transplant, although the child finally died from
sepsis. After this reportthe combination ofazathioprine and steroid was accepted
as standard therapy for kidney transplantation. In 1976 cyclosporin A, a fungal
metabolite, was found to be a potent immunosuppressant and is now widely
used, though it too has serious drawbacks. The age of drug immunosuppression
had arrived, and opened up the possibility oftreating end-stage kidney failure by
transplantation.
From the time of Murray and Calne's demonstration in 1962 that cadaveric
transplantation was possible with the aid of azathioprine, it seemed to me that
transplantation would prove to be the definitive treatment of end-stage renal
failure. Good aualitv dialysis theraDv would be needed to make the Datients fit
and maintain them until kidneys could
be provided. If the graft fails, the
patient should survive to return to
dialysis therapy and have a second,
even a third or fourth graft.
My first attempts to put this philosophy
into practice were possible through the
help ofthe few centres in the UK doing
experimental work in transplantation.
Professor Woodruff transplanted one
of my patients from her father in 1962.
She did not survive, but over the years
1965-68 Professor Peart at St Mary's
Hospital, and later ProfessorRoyCalne,
accepted my patients. Figure 5 shows
Professor Calne, by this time Professor
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Fig 5. Professor R Y Caine, FRS, FRCS, with
Mr J Neill, who received a renal transplant in
Cambridge in April 1966.
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ofSurgery in Cambridge, with his longest surviving cadaver transplant, one of my
patients, who was transplanted in April 1966. The graft continues to function
excellently.
Our transplantation programme began in 1968 soon afterthe opening of Renal 1.
A second consultant nephrologist was appointed and surgeons were designated
to take part in the transplantation programme. (Table 1). Some are no longer
working with us - Dr John Hewitt, Dr Joseph McEvoy and Mr Stewart Clarke
have left Northern Ireland, Dr Sam Nelson has left tissue typing. Nurse Kay
Maguire who was the first renal nurse in 1963 and is now our senior nursing
officer, and Mr Jack Lyness, technician since 1960, have both contributed
greatly to the development of the service. I must stress that the good results we
have achieved are due to the efforts of the whole team. I must also pay tribute to
the great help we have received from the staff of intensive care units who have
provided kidney donors. We owe a particular debt of gratitude to the Respiratory
Intensive Care Unit in the Royal Victoria Hospital who have provided by far the
largest number of donors, and to the others who have found kidney donors. The
procurement of a donor entails a considerable amount of extra work for the
doctors and nurses concerned. Our tissue typing service was set up under the
leadership of Dr Sam Nelson. Following his resignation, Dr Derek Middleton has
become head of the service, and indeed has contributed greatly to the develop-
ment of the work over the last 13 years.
TABLE I
Renal transplantation in Belfast
Anaesthetists: J P Alexander, C J Hewitt, J Gamble, C Gardiner.
Nephrologists: M G McGeown, J McEvoy, J F Douglas, C C Doherty.
Surgeons: S Clarke, J A Kennedy, W G Loughridge, R A Donaldson,
R Johnston.
Tissue Typing: S D Nelson, D Middleton.
Nursing Officer: K Maguire (1963).
Chief Technician: J Lyness (1960).
Between 1968 and 1985, 347 patients have received 392 grafts, there being 38
second grafts, six third grafts and one fourth graft. Most of the grafts came from
cadavers, only 36 coming from live donors. Two hundred and forty-five patients
are alive with functioning grafts, and 11 others are alive, having returned to
dialysis after failure of their graft. We had the good fortune to achieve
outstandingly good results of patient and graft survival from the beginning of
our transplantation programme, and over the years since statistics have been
collected centrally, have been at the top of the 'league table'.6
Now after almost 17 years it is possible to identify at least some of the factors
which contribute to our high success rate which has continued over all this time.
The careful organisation ofthe team has resulted in good clinical care. The most
important point in the preparation of the recipient is now known to be the giving
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of blood transfusion, which we have done from the beginning ofour programme,
despite the fact that transfusion was then beginning to be considered a risk factor
rather than helpful. The drugs we have given to prevent rejection of the kidney
were those in general use but we decided to use much lower doses, particularly of
prednisolone, in the hope ofreducing toxicside effects. We hoped to improvethe
results of transplantation by avoiding infection, particularly fatal infection. This
we were able to do, by isolation of the patients through the use of the specially
designed building, and by using very low doses of steroid compared with other
centres.
THE PROBLEMS OF RENAL REPLACEMENT THERAPY
I have described to you a truly marvellous story - the discovery of how the
function of a vital organ may be replaced after failure, permitting life to continue
for years. Indeed the kidney is the only organ where complete failure of function
can be treated. Hard on the heels ofthisdiscovery came the development ofrenal
transplantation. Successful transplantation restores the patient to almost
complete normality. Machine treatment, dietary and fluid restriction become
unnecessary and the patient merely has to take a few pills daily to prevent
rejection. Normal energy is regained, indeed patients with transplants become fit,
even forcompetitive sport. Onepatient starred in therecentvictoryofClandeboye
in the Irish Senior Cup GolfCompetition. Parenthood is possible even forwomen.
One patient has had three successful pregnancies since transplantation. Many
others have had one child and several have had two.
As soon as a new service develops, the demand for it grows rapidly. By the end of
1964 we were treating one patient. It was possible to squeeze in treatment for the
first patient without detriment to the acute programme. The first patient died after
a short time, and other patients followed one by one during 1965. Table 11 shows
the number of patients receiving treatment from 1964 when we began regular
haemodialysis until we moved to Renal I in 1968. The number of patients
transplanted each year is also shown. Thanks to Professor Vallance-Owen, and
the devoted work of Sister Wallace and the nursing staff of Wards 3 and 4 RVH,
two patients were regularly given twice weekly peritoneal dialysis from 1968 until
1972 when Renal 11 was opened. After 1968 the numbers of patients treated
increased slowly year by year (Table III), but this in no way satisfied the demand.
TABLE II
Renal replacement therapy in Belfast 1964.1968
*Number ofpatients Numnber ofpatients
Year on treatment transplanted
1964 1 2
1965 1 2
1966 4 3
1967 4 2
1968 8** 7
*Patients on treatment at any one time.
*Includes 2 patients in Ward 3, RVH.
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TABLE III
Renal replacement therapy in Belfast 1969-1985
*Number ofpatients Number ofpatients
Years on treatment transplanted
1969-72 8 16
1972-73 20 31
1974-78 30 106
1979-80 37-39 61
1981 40 25
1982 46 46
1983 50 38
1984 55 37
1985 65 34
*Patients on treatment at any one time including PD.
Since 1978 the increased efficiency of the dialysis equipment, and technical
advances in general, have allowed the duration of dialysis to be progressively
reduced from 28 to 16 hours weekly for an average-sized adult. We give the
weekly treatment divided into two sessions. Most other centres give it in three
sessions. This is more costly, which means thatfewer patients can betreated, and
that the patients have to attend on three occasions. My own observations lead me
toconsiderthat twolonger sessions provide adequate treatmentformostpatients,
provided they follow the regular discipline of fluid intake and salt restriction. The
factthat some of our patients have remained reasonably well for as long as seven
years on twice weekly haemodialysis shows that thrice weekly dialysis is in the
nature of a luxury.
The shortfall in facilities has always meant that many patients who could benefit
do not receive treatment. The very success of the treatment compounds the
problem, as relatively few patients die. I have used the figure of 40 patients/
million/year asthe annual incidence ofnewpatients with end-stage renal disease.
This figure is based on a survey carried out during 1969-71 in which many
Northern Ireland doctors took part by filling in letter cards to notify their patients
with renal failure. It refers to patients aged 5-55 years, medically suitable for
treatment, and excludes diabetics, and some other patients who would now be
considered treatable. The problem of the shortfall of facilities has been made
worse because we have progressively expanded the possibilities by showing that
older patientsdoremarkably well ondialysistherapyand canalso betransplanted.
We have transplanted with success up to the age of 65. Moreover, it has been
shown that some diabetics, and even patients with coronary bypass or ileal
conduits, can be transplanted successfully.
How do the facilities available measure up to the needs of our population? You
must bear in mind that the figure of 40 new patients per annum does not permit
us to treat anyone older than 55 years, and does not allow for diabetic or other
disadvantaged patients. It is, however, the target set by the DHSS for all units to
achieve by 1987. A few patients die during the first year but about 83% are alive
i The Ulster Medical Society, 1986.
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at the end of the year to be joined by 40 new patients appearing in the second
year. In the third year 86% of the first set of patients and 93% of the second set
of patients remain to bejoined by the new ones. Even at the end ofthe third year,
80% of the first set of patients remain alive. The number of patients goes on
increasing until eventually equilibrium is reached when the new patients are
equalled by patients dying. The statisticians tell usthat equilibrium will bereached
only after 25 years, but 90% of steady state will be reached after 10 years.
The cost of regular dialysis therapy, of course, escalates year by year as the
number of patients increases. If the programme is expanded to include older
people, diabetics and other disadvantaged patients, more will die each year, but
in the meantime they will have had more medical complications and cost more to
treat. It is difficult to arrive at a true cost but several years ago the DHSS costed
hospital haemodialysis at £1 1 - 13,000 per annum, and home dialysis at
£6 - 8,250 per annum. Home haemodialysis costs less but, if the patient
receives a transplant, the cost ofconverting the home is lost and ittakestwo years
of home treatment to break even. Satellite dialysis is nearly as cheap as home
treatment and, as it avoids the cost of converting individual homes, it is the best
buy. However, it is cheaper only because ofthe economy ofstaffing that becomes
possible when only fit stable patients are treated. The saving in cost in the satellite
is, to some extent, offset by increased costs in the mother unit which copes with
the early problems, and accepts back patients who get into difficulties. Moreover,
the older and otherwise disadvantaged patients are not suitable for treatment in a
satellite centre.
Transplantation is cheaper but the immunosuppressive drugs cost about £1,200
per annumor moreif cyclosporin isused. The saving isillusoryas thetransplanted
patient is replaced by a new patient. The transplant often does not cover the life
of the patient, who may need dialysis treatment again. While one of our patients
has had a well-functioning graft for more than 20 years, and 47 for 12.15 years,
the average is less than 10 years. Six patients have had three grafts and one a
fourth graft. We must, however, remember that transplantation provides much
better quality of life than any form of dialysis. While it is not possible for all
patients the contraindications are relatively few. The limitation to transplantation
is the number of donors which can be obtained.
The United Kingdom lags far behind other European countries in its provision for
dialysis treatment, particularly for patients over the age of 45, because of lack of
resources. Dialysis and transplantation are paid for here by the National Health
Service. There is virtually no private dialysis or transplantation, except in London,
where it is used almost entirely for patients from overseas. In other European
countries, the financial cost of treatment is provided by insurance, and each
treatment is paid for directly. If we lag behind Europe, all Europe lags behind the
United States. In 1972 laws were enacted there which effectively provided
treatment for all American citizens with end-stage renal failure, without charge to
themselves. This led to a phenomenal growth of haemodialysis in America,
where all patients are accepted regardless of age and of other diseases present.
The Medicare budget for end-stage renal failure now approaches three billion
dollars. In America it was considered morally intolerable to ration treatment for
financial reasons, but this rocketing cost has caused a complete re-think. The
medical profession there have been very critical of British nephrologists, blaming
them for accepting rationing of treatment because of limited finance. They are
now having to face the same moral dilemma.
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I put it to you thatthe very success ofourtreatment for end-stage renal failure has
produced a moral and ethical, as well as financial, crisis ofthe first magnitude. All
patients who could benefit cannot be treated. Who then should be treated and
how do we select them? Other advancing medical fields such as heart and liver
transplantation must face these issues also. When resources are limited, how to
resolve the competing claims of 'high-tech' medicine and the care ofthe mentally
handicapped or the elderly? There is no real solution to this moral dilemma. In
Northern Ireland we are on the brink of further development of renal services.
The opening ofthe Tower Block will increase facilities for renal transplantation
but only if a sufficient supply of donors becomes available. However, we can be
cautiously optimistic as fewer kidneys will have to be exported because of lack of
suitable recipients and of beds. The beds vacated by transplantation moving to
the Tower will permit considerable expansion in CAPD, to about 30 new patients
per year. The provision of a satellite dialysis centre in the northwest of the
Province would provide a further small increase in patients. It should eventually
become possible to accept 60 new patients/million/annum, that is 90 for the
Province. Even then there will be hard decisions to be made.
Research into the causes and treatment of kidney diseases holds the prospect
that some types of end-stage renal disease may be prevented, or at least delayed
in onset. Let me conclude by acknowledging the enormous help which we have
been given by the Northern Ireland Kidney Research Fund.
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